#130857
Re: Farmas USA
entrevistas en el podcast de Ark a David Liu (junio, septiembre, 2021)
entre otras muchas cosas, se comenta DNA helix cutting editing, base editing, prime editing, delivery...
https://ark-invest.com/podcast/ep-99-david-liu/
https://ark-invest.com/podcast/ep106-therapeutic-human-gene-editing/
entre otras muchas cosas, se comenta DNA helix cutting editing, base editing, prime editing, delivery...
https://ark-invest.com/podcast/ep-99-david-liu/
https://ark-invest.com/podcast/ep106-therapeutic-human-gene-editing/
David is a Richard Merkin Professor, Director of the Merkin Institute of Transformative Technologies in Healthcare, and Vice-Chair of the Faculty at the Broad Institute of Harvard and MIT, as well as the scientific founder or cofounder of six biotechnology and therapeutics companies, including Editas, Exo Therapeutics, Beam Therapeutics, and Prime Medicine. He himself went to Harvard and graduated first in his class, and he has since published more than 195 scientific papers and is the inventor of 75+ issued U.S. patents.